The landscape of malignancy treatment is constantly evolving, with a growing focus on identifying novel therapeutic targets for drug creation. Traditional therapies often attack rapidly dividing cells, leading to significant side consequences. However, the emergence of sophisticated genomic profiling techniques has altered our understanding of tumo